The Gradual Release of Alendronate for the Treatment of Critical Bone Defects in Osteoporotic and Control Rats.
Lukasova VeraRadmila ŽižkováMatěj BuzgoLucie VištejnováPavel KleinMaria HovořákováMartin BartošKlára SteklíkováJitka LuňáčkováEva ŠebováIveta PaurováMiroslava RysovaEva FilováMichala RampichováPublished in: International journal of nanomedicine (2023)
The prepared scaffolds enabled tunable control release of ALN. The effect of ALN was proved in vitro and in in vivo study supported peri-implant bone formation.